Elimination of Indocyanine Green in the Perioperative Evaluation of Donor Liver Function

作者
Mercedes Susan Mandell,Michael E. Wachs,Claus U. Niemann,Thomas K. Henthorn
出处
期刊:Anesthesia & Analgesia [Lippincott Williams & Wilkins]
卷期号:95 (5): 1182-1184 被引量:19
标识
DOI:10.1097/00000539-200211000-00010
摘要

Failure of the donor liver graft soon after transplantation is a life-threatening complication that usually requires emergent retransplantation. Patient mortality is increased, and the pool of scarce organs available to other potential transplant recipients is reduced. Acute failure of the donor liver graft is usually due to unrecognized parenchymal injury during the process of donation or technical difficulties that occur during vascular reconstruction, impairing blood flow to the graft (1). Rapid perioperative diagnosis of graft dysfunction would improve physician decision-making and, consequently, patient outcome. Although it is difficult to improve graft function caused by cellular injury or death, reversible ischemic injuries due to technical problems in vascular construction are potentially correctable if detected early. In this report, we describe how noninvasive indocyanine green (ICG) dye elimination identified a critical reduction in hepatic function. This observation led to a change in clinical management that significantly improved the outcome. Case Report Institutionally approved written, informed consent was obtained from a transplant recipient to participate in a larger study evaluating the perioperative recirculatory kinetics of ICG (2). A 46-yr-old man with hepatitis C, waiting for transplantation, was admitted to the intensive care unit (ICU) with ascites, renal failure, and progressive encephalopathy. A cadaveric liver became available on the ninth day after admission. In the operating room, ICG elimination was determined after the induction of general anesthesia, excision of the native liver, and reperfusion of the donor graft. Studies were repeated on the first postoperative day. Elimination slopes (K) were estimated from a noninvasive integrated pulse-spectrophotometric monitor (Nihon Kohden, Saitama, Japan) after a 10-mg bolus dose of ICG was injected into a central venous catheter. The transcutaneous probe of the monitor placed on the external nares emits wavelengths of 805 and 940 nm to measure arterial ICG concentration. The arterial hemoglobin concentration was measured before ICG injection. The device calculated kinetic estimates for cardiac output (CO), blood volume, and ICG K values by using standard equations from the dye dilution history. CO was estimated with the Stewart-Hamilton approach, and blood volume was estimated by dividing the ICG dose by the back-extrapolated concentration at Time 0. K was estimated by linear regression of the semilog concentration versus time data from t = 2.5 min to t = 5.5 min. After reperfusion of the donor liver, the portal vein appeared patent. There were no signs to suggest donor graft dysfunction, and the patient was hemodynamically stable, with minimal bleeding. However, we suspected significant graft dysfunction because the ICG elimination value of 0.012/min from the reperfused graft was similar to the anhepatic value of 0.009/min (Table 1). An intraoperative ultrasound was performed to independently assess hepatic blood flow, and a vein graft was inserted after we confirmed a critical reduction in portal venous blood flow.Table 1: Perioperative ICG Elimination Rate ConstantsThe ICG K improved significantly after reconstruction of the portal vein (Fig. 1, Table 1), and brisk portal venous flow was confirmed by ultrasound. A dye study conducted during the first postoperative day in the ICU showed progressive improvement in the K (Table 1), and ultrasonography showed hepatic blood flow to be unchanged. The patient had an uneventful recovery and was discharged from the hospital on postoperative Day 11.Figure 1: Arterial blood indocyanine green (ICG) concentration histories for Minutes 1 through 9 after rapid central venous injection during the five distinct surgical phases listed in Table 1 and described in the text. The reduction in ICG clearance during Phases I, II, and III is consistent with a lack of portal vein flow. There was dramatic improvement in the slope of the ICG concentration versus time curve once portal flow was restored. This improvement continued into the first postoperative day. Note that there was a significant motion artifact in the postoperative study when the patient was conscious. However, this did not affect the results.Discussion We identified donor liver dysfunction by using noninvasive ICG elimination data generated instantaneously at the bedside. The data suggested failure to reestablish adequate hepatic blood flow, a finding confirmed by ultrasonography and not previously reported for ICG testing during liver transplantation. This early diagnosis affected a change in clinical management that probably prevented subsequent graft failure and the need for retransplantation. ICG dye dilution is often used to measure liver function, blood volume, and CO (3,4). The dye is rapidly extracted from the blood only by the liver and is excreted in the bile unchanged (5,6); enterohepatic circulation and metabolism of the parent compound do not occur (7). Thus, only hepatic blood flow, extraction, and biliary transport determine clearance. Because ICG is extracted and eliminated according to first-order kinetics, ICG dye dilution is an excellent estimation of global liver function (8). Dye elimination correlates with donor graft function (9–11) and is a sensitive test capable of identifying reperfusion injury (9). However, standard testing is currently limited by the cumbersome technique of measuring the ICG concentration in serial blood samples. The extended time for standard analysis and reporting of results makes this a valuable test of hepatic function impractical in the operating room. Estimation of the same variables by the novel noninvasive technique compares favorably with standard techniques, and results are readily available at the bedside (12,13). Although dye elimination correlates well with postoperative liver function (10,11), investigators are unable to agree on a single clearance or elimination value that predicts outcome in all patients. Rather than use previously published values, we compared dye elimination during surgery with a baseline value measured after the induction of anesthesia. Although most measurements were made during surgery, ICG elimination is not affected by general anesthesia (4). The marked decline in dye elimination that our patient experienced after excision of the liver is easily explained by the near-complete interruption of hepatic blood flow. We were surprised that the dye-elimination rate did not increase after reperfusion, because previous studies have shown a rapid increase in ICG elimination curves within one hour of perfusion of the donor graft (12). It is unlikely that these changes were due to physiological perturbations associated with transplantation, because the CO and estimated blood volume remained relatively constant throughout surgery. The similarity of our anhepatic to reperfusion results suggested insufficient blood flow to the liver. We used ultrasonography to distinguish between hepatocellular dysfunction and impaired blood flow. Dye elimination improved significantly after surgical repair reestablishing portal blood flow. The continued improvement in ICG elimination observed in the ICU suggested improved donor graft function and is similar to findings from other studies (11). The diagnosis of hepatic dysfunction and insufficient blood flow is usually based on clinical judgment, because there are no quantitative tests that could provide rapid analysis of hepatic function in the operating room. Our findings are novel in that they are the first to describe the diagnosis of intraoperative donor liver dysfunction on the basis of objective information. In our case, early diagnosis led to a change in surgical management that improved liver function. We suggest that the technique of noninvasive ICG analysis may fill this diagnostic void by providing rapid data on hepatic function. The role of this tool as a multidimensional aid to evaluation of liver function during and after transplantation deserves further consideration.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
王荣光完成签到,获得积分10
1秒前
Code_king发布了新的文献求助10
1秒前
1秒前
一棵树完成签到 ,获得积分10
1秒前
自由念露发布了新的文献求助10
1秒前
杨123完成签到,获得积分10
1秒前
2秒前
L1vekk发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
2秒前
健壮的海蓝完成签到,获得积分10
3秒前
迷路路人完成签到,获得积分10
3秒前
buld完成签到,获得积分10
3秒前
dzx发布了新的文献求助10
3秒前
斯文败类的应助被剪刀手采纳,获得10
4秒前
youtime发布了新的文献求助10
4秒前
WAN完成签到,获得积分10
4秒前
饱满山兰完成签到,获得积分10
5秒前
pyyyyyy完成签到,获得积分20
5秒前
甜瓜甜完成签到,获得积分10
5秒前
5秒前
5秒前
Code_king发布了新的文献求助10
5秒前
Code_king发布了新的文献求助10
5秒前
zzh完成签到,获得积分10
6秒前
6秒前
DW的应助被黃硯禮采纳,获得10
6秒前
leey发布了新的文献求助10
6秒前
6秒前
xz完成签到,获得积分10
7秒前
7秒前
wjl发布了新的文献求助10
7秒前
Akim的应助被成就的笑翠采纳,获得30
7秒前
pyyyyyy发布了新的文献求助10
8秒前
无极微光的应助被从容的绿蝶采纳,获得20
8秒前
在水一方的应助被zsk12138采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176287
求助须知:如何正确求助?哪些是违规求助? 9567719
关于积分的说明 21794359
捐赠科研通 7771008
什么是DOI,文献DOI怎么找? 3431998
关于科研通互助平台的介绍 2556315
邀请新用户注册赠送积分活动 2477650